Home ETF List About

ETF Holdings Breakdown of AUPH

Stock NameAurinia Pharmaceuticals Inc
TickerAUPH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINCA05156V1022

AUPH institutional holdings

The adjusted close for AUPH on 2025-11-12 was 15.54

The following institutional investment holdings of AUPH have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-12 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 94,485USD 1,468,297 -0.9% 15.54  
2025-11-12 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 16,096 -0.3%USD 250,132 -1.2% 15.54  
2025-11-12 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 163,035USD 2,533,564 -0.9% 15.54  
2025-11-12 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 84,743 0.3%USD 1,316,906 -0.6% 15.54  
2025-11-12 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 84,743 0.3%USD 1,316,906 -0.6% 15.54  
2025-11-12 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 823USD 12,789 -0.9% 15.54  
Total =443,925 USD 6,898,594
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with AUPH

Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High on Analyst Upgrade
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH – Get Free Report) (TSE:AUP)’s stock price reached a new 52-week high during mid-day trading on Monday after Royal Bank Of Canada raised their price target on the stock from $8.00 to $9.00. Royal Bank Of Canada currently has an outperform rating on the stock. Aurinia Pharmaceuticals traded as high as […] - 2025-08-05 02:22:49
Aurinia Pharmaceuticals (NASDAQ:AUPH) Price Target Raised to $9.00
Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) had its price target upped by Royal Bank Of Canada from $8.00 to $9.00 in a report released on Friday,Benzinga reports. The brokerage currently has an outperform rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $17.00 price target on shares […] - 2025-08-04 04:59:02
Xponance Inc. Acquires New Position in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Xponance Inc. acquired a new stake in shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH – Free Report) (TSE:AUP) during the 1st quarter, Holdings Channel reports. The fund acquired 10,146 shares of the biotechnology company’s stock, valued at approximately $82,000. Several other institutional investors and hedge funds have also modified their holdings of the company. Tang Capital […] - 2025-07-21 05:02:57
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Passes Below 200 Day Moving Average – Should You Sell?
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH – Get Free Report) (TSE:AUP)’s stock price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $8.22 and traded as low as $7.81. Aurinia Pharmaceuticals shares last traded at $7.92, with a volume of 1,048,653 shares traded. […] - 2025-06-20 05:11:03
Bank of America Corp DE Has $574,000 Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Bank of America Corp DE decreased its stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 63.4% in the fourth quarter, HoldingsChannel reports. The firm owned 63,975 shares of the biotechnology company’s stock after selling 110,715 shares during the period. Bank of America Corp DE’s holdings in Aurinia Pharmaceuticals were worth $574,000 at […] - 2025-06-11 04:44:43
ProShare Advisors LLC Boosts Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
ProShare Advisors LLC lifted its stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 31.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 44,588 shares of the biotechnology company’s stock after purchasing an additional 10,771 shares during the period. ProShare Advisors LLC’s holdings in Aurinia Pharmaceuticals were worth $400,000 as of […] - 2025-05-28 06:22:59
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock Position Raised by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 3.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 76,314 shares of the biotechnology company’s stock after purchasing an additional 2,887 shares during the period. MIRAE ASSET […] - 2025-05-28 04:52:53
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Bought by Nuveen Asset Management LLC
Nuveen Asset Management LLC boosted its holdings in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 10.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,492,301 shares of the biotechnology company’s stock after buying an additional 138,054 […] - 2025-05-27 05:16:53
Graham Capital Management L.P. Makes New Investment in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Graham Capital Management L.P. acquired a new position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) in the 4th quarter, HoldingsChannel reports. The firm acquired 11,409 shares of the biotechnology company’s stock, valued at approximately $102,000. Other large investors also recently bought and sold shares of the company. SBI Securities Co. Ltd. […] - 2025-05-20 06:15:10
Gotham Asset Management LLC Has $404,000 Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Gotham Asset Management LLC boosted its holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 8.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 44,996 shares of the biotechnology company’s stock after buying an additional 3,655 shares during the period. Gotham […] - 2025-05-20 05:38:53
Notable Two Hundred Day Moving Average Cross - AUPH
In trading on Wednesday, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) crossed below their 200 day moving average of $7.71, changing hands as low as $7.47 per share. Aurinia Pharmaceuticals Inc shares are currently trading down about 2.6% on the day. The chart below sho - 2025-05-14 12:56:31
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Position Lifted by Hsbc Holdings PLC
Hsbc Holdings PLC raised its stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 48.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 15,616 shares of the biotechnology company’s stock after acquiring an additional 5,080 shares during the period. Hsbc Holdings PLC’s holdings in Aurinia Pharmaceuticals were worth $141,000 as of […] - 2025-05-12 04:56:51
Barclays PLC Has $2.19 Million Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Barclays PLC raised its position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 11.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 243,948 shares of the biotechnology company’s stock after purchasing an additional 24,617 shares during the quarter. Barclays PLC’s holdings in Aurinia Pharmaceuticals were worth $2,190,000 at the end […] - 2025-05-02 06:02:58
Renaissance Technologies LLC Boosts Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Renaissance Technologies LLC boosted its position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 44.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 700,900 shares of the biotechnology company’s stock after purchasing an additional 214,200 shares during the quarter. Renaissance Technologies LLC […] - 2025-04-20 05:00:52
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Purchased by Federated Hermes Inc.
Federated Hermes Inc. grew its holdings in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 1,233,875.0% during the fourth quarter, Holdings Channel reports. The firm owned 49,359 shares of the biotechnology company’s stock after acquiring an additional 49,355 shares during the quarter. Federated Hermes Inc.’s holdings in Aurinia Pharmaceuticals were worth $443,000 […] - 2025-04-18 04:57:07
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Acquired by Franklin Resources Inc.
Franklin Resources Inc. increased its stake in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 358.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 92,921 shares of the biotechnology company’s stock after purchasing an additional 72,668 shares during […] - 2025-04-16 05:11:01
Wellington Management Group LLP Invests $546,000 in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Wellington Management Group LLP purchased a new stake in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 60,751 shares of the biotechnology company’s stock, valued at approximately $546,000. Other large investors also recently added […] - 2025-04-15 04:50:51
ExodusPoint Capital Management LP Takes Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
ExodusPoint Capital Management LP purchased a new position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) during the fourth quarter, Holdings Channel reports. The institutional investor purchased 53,500 shares of the biotechnology company’s stock, valued at approximately $480,000. Several other hedge funds and other institutional investors have also bought and sold shares […] - 2025-04-13 05:33:20
Teacher Retirement System of Texas Buys 2,020 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Teacher Retirement System of Texas increased its stake in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 5.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,098 shares of the biotechnology company’s stock after buying an additional […] - 2025-04-02 05:16:55
Aurinia Pharmaceuticals (NASDAQ:AUPH) versus Entrada Therapeutics (NASDAQ:TRDA) Head-To-Head Comparison
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) and Entrada Therapeutics (NASDAQ:TRDA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, earnings, dividends and risk. Institutional & Insider Ownership 36.8% of Aurinia […] - 2025-04-01 02:40:45
Swiss National Bank Sells 26,200 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Swiss National Bank decreased its holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 9.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 239,000 shares of the biotechnology company’s stock after selling 26,200 shares during the period. Swiss National Bank’s holdings in […] - 2025-03-28 07:44:57

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.